Trial Profile
AN OPEN LABEL CLINICAL STUDY TO EVALUATE THE LONG-TERM DERMAL SAFETY PROFILE OF 12-WEEKS TOPICAL ADMINISTRATION OF TWO DIFFERENT DOSES OF N-ACETYL-GED-0507-34-LEVO GEL IN PATIENTS WITH MILD TO MODERATE FACIAL ACNE
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs GED 0507 34 Levo (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions; Pharmacokinetics
- 05 Mar 2018 Status changed from not yet recruiting to completed.
- 12 Feb 2018 New trial record